Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

Journal of the American College of Cardiology

Volumn 39, Issue 10, 2002, Pages 1615-1622

  Zugck, Christian ^a   Haunstetter, Armin ^a   Krüger, Carsten ^a   Kell, Robert ^a   Schellberg, Dieter ^a   Kübler, Wolfgang ^a   Haass, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NORADRENALIN; WARFARIN;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATION; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NORADRENALIN BLOOD LEVEL; OUTCOMES RESEARCH; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; NOREPINEPHRINE; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0037094258     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01840-5     Document Type: Article

References (27)

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
3. Effect of metoprolol CR/XL in chronic heart failure: MEtoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure (MERIT-HF)
4. Effect of carvedilol on survival in severe chronic heart failure
5. The treatment of heart failure
6. Guidelines for the evaluation and management of heart failure (ACC)
7. Beta-blocker treatment in heart failure
8. Treatment of heart failure with beta-blockers: Mechanisms and results
9. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
10. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study
11. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular, arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure
12. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit
13. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects
14. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
15. Respiratory, muscle dysfunction in congestive heart failure: Clinical correlation and prognostic significance
16. Prognostic value of Doppler echoeardiographic mitral inflow patterns: Implications for risk stratification in patients with chronic congestive heart failure
17. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
18. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
19. The role of exercise based prognosticating algorithms in the selection of patients for heart transplantation
20. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatoty patients with heart failure
21. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 ml/kg/min revisited
22. Risk stratification in middle aged patients with congestive heart failure: Prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two variable model
23. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
24. Carvedilol produces dose-dependent improvements in left ventricular function and survival in subjects with chronic heart failure
25. Comparative hemodynamic, left ventrieular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvcdilol in the failing heart
26. The registry of the international society, for heart and lung transplantation: Seventeenth official report, 2000
27. Effect of receiving a heart transplant: Analysis of a national cohort entered onto a waiting list, stratified by heart failure severity